Endothelial dysfuncton and 2 type diabetes: novel markers for earlier diagnostics

Aim. To assess clinical significance of the novel ultrasound and biochemical markers of endothelial dysfunction (ED) in men with 2 type diabetes (DM2).

Material and methods. Totally, 200 males studied, with DM2, of those 112 selected (mean age 51,7±6,7 y.) with normal vascular reactivity by Celermajer D. (1994). function of endothelium was assessed by ultrasound study of arterial vessel reactivity of brachial artery (BA) during the test with reactive hyperaemia and proteomic markers of ED — nitric oxide, endothelial nitric oxide synthase type 3 (NOS3), adhesion molecules ICAM-1, VCAM-1, p-selectin, e-selectin, resistin, osteoprotegerin, immune-enzyme assay. Patients were selected to 2 groups by presence or absence of polymorphism с.582+353_379del gene eNOS3.

Results. Regardless the absence of ED signs by standard test with reactive hyperaemia, patients with deletion of 27 pair of nucleotides in 4 intron of non-coding area of eNOS3 gene had increased concentrations of adhesion molecules VCAM-1 by 27% and ICAM-1 by 22,9%, as the decrease of eNOS3 by 55,7%, that followed by slowed maximum vasodilation of BA during the test, comparing to the males not having this polymorphism. The significant positive correlations found of the time of maximum vasodilation development with proteomic markers of ED ICAM-1 and VCAM-1.

Conclusion. For the first time, a complex of parameters established — time to maximum BA dilation with increased concentration of proteomic markers ICAM-1, VCAM-1 and decrease of eNOS3 that points on the role of ED earlier than BA diameter changes during the reactive hyperaemia test.

1. IDF Diabetes Atlas. 7-th edition. 2015. Available from: www.idf.org/diabetesatlas/7e/

2. Engelgau M.M., Narayan K.M., Herman W.H. Screening for type 2 diabetes. Diabetes care. 2000; 23 (10): 1563–1580.

3. Polovina M.M., Potpara T.S. Endothelial dysfunction in metabolic and vascular disorders. Postgrad Med. 2014; 126 (2): 38-53.

4. Bonetti P.O., Lerman L.O., Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arteriosclerosis, thrombosis, and vascular biology. 2003; 23: 168–175.

5. Ruggiero D., Paolillo S., Ratta G.D. et al. Endothelial function as a marker of pre-clinical atherosclerosis: assessment techniques and clinical implications. Monaldi Arch. Chest. Dis. 2013; 80 (3): 106-110.

6. Khripun I.A., Gusova Z.R., Ibishov H.S. et al. Endothelial dysfunction in men – a clinical view (literature review). Bulletin of Sibirian medicine. 2014; 4: 19-22. Russian (Хрипун И.А., Гусова З.Р., Ибишев Х.С., и др. Эндотелиальная дисфункция у мужчин – взгляд клинициста (обзор литературы). Бюллетень сибирской медицины. 2014; 4: 19-22)

7. Flammer A.J., Luscher T.F. Three decades of endothelium research: from the detection of nitric oxide to the everyday implementation of endothelial function measurements in cardiovascular diseases. Swiss. Med. Wkly. 2010; 140: 13122.

8. Manual Cardiology in four volumes. Volume 2: Methods for diagnosing cardiovascular disease. / Pod red. E.I. Chazova. M.: Praktika; 2014 Russian (Руководство по кардиологии в четырех томах. Том 2: Методы диагностики сердечно-сосудистых заболеваний. / Под ред. Е.И. Чазова. М.: Практика; 2014)

9. Harris R.A., Nishiyama S.K., Wray D.W., et al. Ultrasound assessment of flow-mediated dilation. Hypertension. 2010; 55: 1075–1085.

10. Arrebola-Moreno A.L., Laclaustra M., Kaski J.C. Noninvasive assessment of endothelial function in clinical practice. Rev. Esp. Cardiol. 2012; 65 (1): 80-90.

11. Förstermann U., Sessa W.C. Nitric oxide synthases: regulation and function. Eur. Heart J. 2012; 33 (7): 829-337, 837a-837d.

12. Vecoli C. Endothelial nitric oxide synthase gene polymorphisms in cardiovascular disease. Vitam Horm. 2014; 96: 387-406.

13. Khripun I.A., Vorobyev S.V., Morgunov M.N., et al. Genetic aspects in formation of disturbance of endothelial function in patients with type 2 diabetes. Medical news of North Caucasus. 2015; 10 (4): 339-343. Russian (Хрипун И.А., Воробьев С.В., Моргунов М.Н., и др. Генетические аспекты формирования нарушения функции эндотелия у больных сахарным диабетом 2 типа. Медицинский вестник Северного Кавказа. 2015; 10 (4): 339-343)

14. Khripun I.A, Morgunov M.N., Vorobyev S.V., et al. A screening method of patients with type 2 diabetes at risk for the development of endothelial dysfunction. Zayavka na patent registratsionnyiy nomer 2015140824 ot 24.09.2015. Russian (Хрипун И.А, Моргунов М.Н., Воробьев С.В., и др. Способ отбора пациентов с сахарным диабетом 2 типа в группу риска по развитию эндотелиальной дисфункции. Заявка на патент регистрационный номер 2015140824 от 24.09.2015)

15. Khripun I.A., Vorobyev S.V., Puzyireva V.P., et al. Dysfunction of endothelium, as a result of androgen deficiency in men with type 2 diabetes. Sovremennyie problemyi nauki i obrazovaniya. 2015; 6: 220. Russian (Хрипун И.А., Воробьев С.В., Пузырева В.П., и др. Дисфункция эндотелия, как следствие андрогенного дефицита у мужчин с сахарным диабетом 2 типа. Современные проблемы науки и образования 2015; 6: 220).